BRIGHT MINDS BIOSCIENCES INC. Cash Flows From Used In Operating Activities
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Cash Flows From Used In Operating Activities of -CAD 1.85 million for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Cash Flow
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2024-12-31
| Period end | Cash Flows From Used In Operating Activities 4 month | Cash Flows From Used In Operating Activities 12 month |
|---|---|---|
| 2024-09-30 | -1.85M CAD 20-F · filed 2024-12-31 | |
| 2023-09-30 | -7.02M CAD 20-F · filed 2024-12-31 | |
| 2022-09-30 | -13.59M CAD 20-F · filed 2024-12-31 | |
| 2021-09-30 | -7.32M CAD 20-F · filed 2023-12-29 | |
| 2020-09-30 | -288.39K CAD 20-F · filed 2022-12-29 | |
| 2019-09-30 | -42.01K CAD 20-F/A · filed 2022-01-18 |